packageInebilizumab

inebilizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Inebilizumab is a monoclonal antibody used to treat neuromyelitis optica. It is an approved immunosuppressant authorised in the European Union, though not yet widely used.

Summary written by glm-5.3-flash from Wikidata Q25326696 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:inebilizumab
ATC codes:L04AG10
DrugBank:DB12530
Wikidata:Q25326696
molar mass:149000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown